GRACE is excited to bring to our Spanish speaking community - Cancer Basics Dr. Duma is an Assistant Professor and Thoracic Oncologist at @UWcarbone...
GRACE is excited to bring you new information in our Bladder Cancer Program, hosted by Ramy Sedhom, MD. For this first video of 2019, Dr. Ramy Sedhom...
GRACE is very excited to bring you more of our program on supportive care in cancer treatment. Arjun Gupta, MD, one of the GRACE Fellows Ambassador...
We are very excited to bring to you more information through our new program regarding supportive care in cancer treatment. Arjun Gupta, MD, one of...
We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...
Dr. Jack West reviews the Lung Cancer Master Protocol for second line treatment of patients with advanced squamous NSCLC, an "umbrella protocol" in which all patients undergo molecular testing and have treatment assigned by the results.
Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.
On this Thanksgiving Day, we salute lung cancer patient Jason Karg and his wife Kristyl for reminding us of the important things in life. November is Lung Cancer Awareness Month. What are you grateful for?
Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.
Dr. Ross Camidge discusses a clinical trial studying patients with advanced stage lung cancer to identify those who may respond to a drug called ponatinib. Both small cell and non small cell lung cancer patients may be eligible. http://bit.ly/UCponatinib
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.